Tag: BPH

UroLift

12-month data show UroLift system a good treatment option for men...

Twelve-month data from the multicentre prospective MedLift study of the Urolift system (NeoTract, a Teleflex subsidiary) for benign prostatic hyperplasia (BPH) involving a median...

Real-time imaging: Ultrasound detects a biodegradable embolic microsphere after prostatic artery...

Researchers report the use of ultrasound to detect embolization in real time for patients undergoing treatment for benign prostatic hyperplasia (BPH). Richard Owen (University...

Prostatic artery embolization improves BPH symptoms nearly as much as TURP...

A randomised, open label trial that was published in the BMJ on 19 June 2018 suggests that the improvement in lower urinary tract symptoms...

Multicentre UK registry results highlight embolization strengths and importance of physician...

First results from the UK-ROPE multicentre registry reveal that prostatic artery embolization is highly effective in reducing lower urinary tract symptoms in men with benign prostatic obstruction.

Randomised trial finds prostatic artery embolization “a real treatment alternative” to...

Six-month results from a prospective, randomised, non-inferiority study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE; 16–20 September, Copenhagen, Denmark) reveal...
urolift

Teleflex completes acquisition of UroLift creator, NeoTract

Teleflex has announced the completion of its previously announced acquisition of NeoTract. Founded in 2004, NeoTract is a privately-held medical device company that has developed...

Embosphere receives US FDA de novo classification for prostatic artery embolization

Merit Medical has announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for its Embosphere microspheres. The indication...

High radiation dose to operator with prostatic artery embolization, until imaging...

According to our results, the physician who performs prostatic artery embolization procedures, even with a ceiling suspended shield, would reach the annual radiation limit...

Study suggests adenomatous-dominant benign prostatic hyperplasia could predict successful embolization

A study recently published in Cardiovascular and Interventional Radiology has, for the first time, identified adenomatous-dominant benign prostatic hyperplasia as a predictor of clinical...
Joao Pisco and prostate artery emoblization

1,000-patient study indicates prostate artery embolization remains effective for years

Prostate artery embolization maintains its effectiveness for at least three years after patients undergo the therapy, according to research presented at the Society of...